1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with devazepide in 4 studies
| Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Studies (devazepide) | Trials (devazepide) | Recent Studies (post-2010) (devazepide) |
|---|---|---|---|---|---|
| 26 | 0 | 5 | 780 | 5 | 42 |
| Protein | Taxonomy | 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50) | devazepide (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0009 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0002 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.245 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamec, RE; Budgell, J; Shallow, T | 1 |
| Bourin, M; Colombel, MC; Malinge, M; Vasar, E | 1 |
| Cong, B; Li, S; Ma, C; Meng, Y; Ni, Z; Wen, D; Yu, H | 1 |
| Cong, B; Geng, J; Jia, XX; Liu, JX; Yu, F; Zhang, JG | 1 |
4 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and devazepide
| Article | Year |
|---|---|
Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.
Topics: Agonistic Behavior; Animals; Anxiety; Arousal; Benzodiazepinones; Cats; Devazepide; Dose-Response Relationship, Drug; Escape Reaction; Fear; Indoles; Male; Maze Learning; Meglumine; Predatory Behavior; Pyrazoles; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex, Startle; Retention, Psychology; Stress Disorders, Post-Traumatic | 1997 |
Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.
Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan | 1999 |
Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.
Topics: Animals; Conditioning, Psychological; Devazepide; Male; Morphine Dependence; Naloxone; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Spatial Behavior; Substance Withdrawal Syndrome | 2012 |
Cholecystokinin octapeptide regulates the differentiation and effector cytokine production of CD4(+) T cells in vitro.
Topics: Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Devazepide; Forkhead Transcription Factors; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Pyrazoles; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Sincalide; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |